Resection of pulmonary metastases following chemotherapy for high stage testicular tumors

International Journal of Urology

Volumn 11, Issue 8, 2004, Pages 634-639

  Eskicorapci, Saadettin Y ^a   Ekici, Sinan ^a   Atsu, M Necmettin ^a   Dogan, Riza ^a   Ozen, Haluk ^a,b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Germ cell tumor; Postchemotherapy resection; Surgery; Testicular tumor; Thoracic mass

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ABDOMINAL SURGERY; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; GERM CELL TUMOR; HISTOPATHOLOGY; HUMAN; LUNG METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; THORAX SURGERY; THORAX TUMOR; TREATMENT INDICATION; TUMOR CELL; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FOLLOW-UP STUDIES; GERMINOMA; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORCHIECTOMY; RETROSPECTIVE STUDIES; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 4344614016     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2004.00869.x     Document Type: Article

References (18)

1. Tiffany P, Morse MJ, Bosl G et al. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy of stage III germ cell tumors. Cancer 1986; 57: 978-83.
2. Einhorn L, Williams S, Mandelbaum I, Donahue J. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 1981; 48: 904-8.
3. Sheinfeld J, Bajorin D. Management of postchemotherapy residual mass. Urol. Clin. North Am. 1993; 20: 133-42.
4. Donohue JP, Bihrle R, Foster RS. Evolving concepts in surgical management of testis cancer. Cancer Treat Res. 1992; 59: 89-97.
5. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumours. Cancer 1994; 74: 1329-34.
6. Kulkarni RP, Reynolds KW, Newlands ES. Cytoreductive surgery in disseminated non-seminomatous germ cell tumours of testis. Br. J. Surg. 1991; 78: 226-9.
7. Brenner PC, Herr HW, Morse MJ et al. Simultaneous retroperitoneal, thoracic, and cervical resection of postchemotherapy residual masses in patients with non-seminomatous germ cell tumors of the testis. J. Clin. Oncol. 1996; 14: 1765-9.
8. Hoie J, Stenwig AE, Giercksky KE, Qvist HL, Fossa SD, Ous S. Post chemotherapy tumour residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses? J. Urol. 1991; 145: 300-3.
9. Hartmann JT, Candelaria M, Kuczyk MA, Schmoll HJ, Bokemeyer C. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Eur. J. Cancer 1997; 33: 843-7.
10. Peckham MJ, McElwain TJ, Barret A et al. Combined management of malignant teratoma of the testis. Lancet 1979; 2: 267-73.
11. Stomper PC, Kalish LA, Garnick MB, Richie JP, Kantoff PW. CT and pathologic predictive features of residual mass histological findings after chemotherapy for nonseminomatous germ cell tumors: can residual malignancy or teratoma be excluded? Radiology 1991; 180: 711-14.
12. Fossa SD, Aass N, Ous S et al. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer. J. Urol. 1989; 142: 1239-42.
13. Steyerberg EW, Keizer HJ, Fossaa SD et al. Resection of residual retroperitoneal masses in testicular cancer: evaluation and improvement of selection criteria. Br. J. Cancer 1996; 74: 1492-8.
14. Motzer R, Bosl G, Heelan R et al. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J. Clin. Oncol. 1987; 5: 1064-70.
15. Ozen H, Ekici S, Sozen S, Ergen A, Tekgul S, Kendi S. Resection of residual masses alone: An alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Urology 2001; 57: 323-7.
16. Steyerberg E, Keizer H, Zwartendijk G et al. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis. Br. J. Cancer 1993; 68: 195-200.
17. Loehrer P, Hui S, Einhorn L, Donohue J. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. J. Thorac. Cardiovasc. Surg. 1986; 92: 676-83.
18. Cagini L, Nicholson AG, Horwich A, Goldstraw P, Pastorino U. Thoracic metastasectomy for germ cell tumours: Long term survival and prognostic factors. Ann. Oncol. 1998; 9: 1185-91.